β-Tubulin mutations in ovarian cancer using single strand conformation analysis-risk of false positive results from paraffin embedded tissues

Cancer Letters

Volumn 236, Issue 1, 2006, Pages 148-154

  Gréen, Henrik ^a   Rosenberg, Per ^b   Söderkvist, Peter ^a   Horvath, György ^c   Peterson, Curt ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

tubulin; Mutation analysis; Ovarian cancer; Paclitaxel; SSCA

Indexed keywords

BETA TUBULIN; PACLITAXEL; PARAFFIN;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONFORMATION; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; FALSE POSITIVE REACTIONS; FEMALE; FROZEN SECTIONS; HUMANS; OVARIAN NEOPLASMS; PACLITAXEL; PARAFFIN EMBEDDING; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUBULIN;

EID: 33646080108     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.05.025     Document Type: Article

References (21)

1. Goldspiel B.R. Clinical overview of the taxanes. Pharmacotherapy 17 (1997) 110S-125S
2. Wani M.C., Taylor H.L., Wall M.E., Coggon P., and McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93 (1971) 2325-2327
3. Orr G.A., Verdier-Pinard P., McDaid H., and Horwitz S.B. Mechanisms of Taxol resistance related to microtubules. Oncogene 22 (2003) 7280-7295
4. Sullivan K.F., and Cleveland D.W. Identification of conserved isotype-defining variable region sequences for four vertebrate beta tubulin polypeptide classes. Proc. Natl Acad. Sci. USA 83 (1986) 4327-4331
5. Kavallaris M., Kuo D.Y.S., Burkhart C.A., Regl D.L., Norris M.D., Haber M., and Horwitz S.B. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J. Clin. Invest. 100 (1997) 1282-1293
6. Barlow S.B., Gonzalez-Garay M.L., and Cabral F. Paclitaxel-dependent mutants have severely reduced microtubule assembly and reduced tubulin synthesis. J. Cell Sci. 115 (2002) 3469-3478
7. Giannakakou P., Poy G., Zhan Z., Knutsen T., Blagosklonny M.V., and Fojo T. Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer. Oncogene 19 (2000) 3078-3085
8. Giannakakou P., Sackett D.L., Kang Y.K., Zhan Z., Buters J.T., Fojo T., and Poruchynsky M.S. Paclitaxel-resistant human ovarian cancer cells have mutant beta- tubulins that exhibit impaired paclitaxel-driven polymerization. J. Biol. Chem. 272 (1997) 17118-17125
9. Martello L.A., Verdier-Pinard P., Shen H.J., He L., Torres K., Orr G.A., and Horwitz S.B. Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation. Cancer Res. 63 (2003) 1207-1213
10. Gonzalez-Garay M.L., Chang L., Blade K., Menick D.R., and Cabral F. A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance. J. Biol. Chem. 274 (1999) 23875-23882
11. Monzo M., Rosell R., Sanchez J.J., Lee J.S., O'Brate A., Gonzalez-Larriba J.L., et al. Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations. J. Clin. Oncol. 17 (1999) 1786-1793
12. Tsurutani J., Komiya T., Uejima H., Tada H., Syunichi N., Oka M., et al. Mutational analysis of the beta-tubulin gene in lung cancer. Lung Cancer 35 (2002) 11-16
13. Sale S., Sung R., Shen P., Yu K., Wang Y., Duran G.E., et al. Conservation of the Class I {beta}-Tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel-resistant ovarian cancers. Mol. Cancer Ther. 1 (2002) 215-225
14. Kohonen-Corish M.R., Qin H., Daniel J.J., Cooper W.A., Rivory L., McCaughan B., et al. Lack of beta-tubulin gene mutations in early stage lung cancer. Int. J. Cancer 101 (2002) 398-399
15. Kelley M.J., Li S., and Harpole D.H. Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer. J. Natl Cancer Inst. 93 (2001) 1886-1888
16. Monzo M., Taron M., and Rosell R. Re: genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer. J. Natl Cancer Inst. 94 (2002) 774-776
17. Sale S., Oefner P.J., and Sikic B.I. Re: genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer. J. Natl Cancer Inst. 94 (2002) 776-777
18. Kelley M.J. RESPONSE: Re: genetic analysis of the -Tubulin Gene, TUBB, in non-small-cell lung cancer. J. Natl Cancer Inst. 94 (2002) 777
19. Hasegawa S., Miyoshi Y., Egawa C., Ishitobi M., Tamaki Y., Monden M., and Noguchi S. Mutational analysis of the class I beta-tubulin gene in human breast cancer. Int. J. Cancer 101 (2002) 46-51
20. Williams C., Ponten F., Moberg C., Soderkvist P., Uhlen M., Ponten J., et al. A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am. J. Pathol. 155 (1999) 1467-1471
21. Lamendola D.E., Duan Z., Penson R.T., Oliva E., and Seiden M.V. beta tubulin mutations are rare in human ovarian carcinoma. Anticancer Res. 23 (2003) 681-686